# Implementing Precision Medicine Approaches to Guide Anti-platelet Selection

> **NCT04090281** · PHASE4 · UNKNOWN · sponsor: **University of Southern California** · enrollment: 200 (estimated)

## Conditions studied

- Acute Coronary Syndrome (ACS)
- STEMI - ST Elevation Myocardial Infarction (MI)
- NSTEMI - Non-ST Segment Elevation MI
- Unstable Angina (UA)

## Interventions

- **GENETIC:** CYP2C19 genotyping

## Key facts

- **NCT ID:** NCT04090281
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-13
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-11-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04090281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04090281, "Implementing Precision Medicine Approaches to Guide Anti-platelet Selection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04090281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*